ACTRN12614000843651已完成未知
Randomised controlled trial to compare the effectiveness of remote monitored exercise-based cardiac rehabilitation with supervised exercise in people with cardiovascular disease to enhance exercise capacity.
niversity of Auckland0 个研究点目标入组 162 人开始时间: 2014年8月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 162
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Aged 18+ years
- •Have a diagnosis of ischaemic heart disease (angina, myocardial infarction or coronary revascularisation) within the previous three months;
- •Outpatients who have been clinically stable for at least 6 weeks, are able to perform exercise, understand and write English
排除标准
- •1.Have been admitted to hospital with heart disease within the previous 6 weeks
- •2.Have terminal cancer
- •3.Currently exercises for 150 minutes per week at moderate intensity
- •4.Currently participating in a supervised exercise programme (including exercise-based cardiac rehabilitation)
- •5.Have significant exercise limitations other than IHD
研究者
相似试验
尚未招募
不适用
A study of the effect of fentanyl boluses versus infusion on surgical plethysmographic index during surgeryCTRI/2020/11/029056Kasturba Medical College
已完成
不适用
Randomised controlled trial to compare the effects of granulocyte-colony stimulating factor (G-CSF) and autologous bone marrow progenitor cells infusion on quality of life and left ventricular function in patients with heart failure secondary to ischaemic heart diseaseHeart failureISRCTN68837678Barts and the London NHS Trust (UK)300
进行中（未招募）
3 期
A clinical trial comparing daily versus intermittent vitamin D supplementation in children with nephrotic syndromeCTRI/2020/04/024598Jawaharlal Nehru medical college
招募中
不适用
Diet and exercise in diabetes patients with SarcopeniaCTRI/2022/04/042186INDIAN COUNCIL OF MEDICAL RESEARCH
进行中（未招募）
不适用
Repeated application of bone marrow-derived stem cells to treat chronicpost-infarction heart failureChronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-IIIand with open vessel / bypass sullpying the previously infarcted areaEUCTR2011-000595-33-NLGoethe University Frankfurt676